What technical signals does Humacyte (HUMA) have?

Humacyte current technical signals: no active technical signal.

Is Humacyte a cup-and-handle pattern?

No. Humacyte has no valid Cup signal right now.

What published figures are available for Humacyte?

Market cap: $100.65M. Trailing 12 months PER: -1.3×. Latest quarter PBR: 3.91×. Dividend yield: 0.00%.

← Signal Board

Humacyte stock price

휴마사이트NASDAQ:HUMA · Nasdaq · Healthcare

$0.5215+3.70%

2026-10-02 close

Today's signals · No active technical signal.

Signal details →

Humacyte last closed at $0.5215 (+3.70%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -1.3×. Its overall grade ranks 678 of 739 stocks in Healthcare.

About this company

Humacyte last closed at $0.5215 (+3.70%) on 2026-10-02. Listed on Nasdaq.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall F · 678/739

Valuation grade D

Details →

Related stocks

Baxter InternationalCustomer
Humacyte의 혈관 이식재 상용화·유통 협력 대상
MedtronicCompetitor
혈관·심혈관 수술용 의료기기 및 재건 치료 영역의 대형 경쟁사
W. L. Gore & AssociatesCompetitor
혈관 이식재·혈관 대체재 분야의 강력한 경쟁 제품 보유

Details →

About Humacyte

What technical signals does Humacyte (HUMA) have?: Humacyte current technical signals: no active technical signal.
Is Humacyte a cup-and-handle pattern?: No. Humacyte has no valid Cup signal right now.
What published figures are available for Humacyte?: Market cap: $100.65M. Trailing 12 months PER: -1.3×. Latest quarter PBR: 3.91×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Turn what you saw on this name into a strategy

Ask Q about Humacyte, or open the plan table on the main site.

Ask Q ↗See plans ↗

From the names you found to a trading rule

Tell Q about the stocks you found to place orders with your conditions.

See plans ↗

Quantus Signal · live data · not investment advice · Privacy Policy